Laparoscopic Partial Nephrectomy: Effect of Warm Ischemia on Serum Creatinine.
Wednesday, 03 November 2004
BERKELEY, CA (UroToday Inc.) - How much warm ischemia time does it take to permanently damage the human kidney?
read more
|
Laparoscopic Cryoablation of Solid Renal Masses: Intermediate Term Follow-Up.
Wednesday, 03 November 2004
BERKELEY, CA (UroToday Inc.) - Needle ablative therapy for small renal cell carcinomas continues to be a hot (or in this case "cold") topic in Urology.
read more
|
Intraoperative Local Anesthesia Decreases Postoperative Parenteral Opioid Requirements for Transperitoneal Laparoscopic Renal and Adrenal surgery: a randomized, Double-Blind, Placebo Controlled Investigation.
Tuesday, 02 November 2004
BERKELEY, CA (UroToday Inc.) - In this prospective study, 72 patients undergoing standard laparoscopy or hand-assisted laparoscopy were randomized to receive 30cc of 0.5% bupivacaine injected at the outset of the procedure (15 ml into the handport site and 15 ml equally divided up among the other ports or 30 ml divided among all the ports in the standard laparoscopy group).
read more
|
Disclosure of Misattributed Paternity in Living Related Kidney Donors Creates a Rare but Possible Ethical Issue
Thursday, 28 October 2004
BERKELEY, CA (UroToday Inc.) - As demand for kidneys from deceased donors continues to outpace their availability, there has been an increasing reliance on the use of related and unrelated living donors.
read more
|
Validation of Metastatic Renal Cell Carcinoma Patient Cohorts to in Order to Evaluate Prognostic Factors for Future Studies.
Wednesday, 27 October 2004
BERKELEY, CA (UroToday Inc.) - The prognosis for long-term survival in patients with metastatic renal cell carcinoma is poor, with 5-year survival ranging from 0%-20%. Identification of a reliable database of prognostic factors in patients with metastatic disease would provide an important tool to help optimize patient selection for specific treatment strategies.
read more
|
Whole Body MRI Rapidly Scans for Metastases
Thursday, 14 October 2004
NEW YORK (Reuters Health) - The results of whole body magnetic resonance imaging (MRI) compare well with other methods of evaluating metastases and can be done rapidly, German researchers report in the October issue of Radiology.
read more
|
Laparoscopic Nephrectomy in Elderly Patients is as Safe as in Younger Patients
Tuesday, 12 October 2004
BERKELEY, CA (UroToday Inc.) - Laparoscopic renal surgery is suggested to provide oncologic equivalency to open renal surgery, yet it also facilitates patient recovery and return to full activity.
read more
|
Laparoscopic Radical Nephrectomy in the Elderly
Monday, 11 October 2004
BERKELEY, CA (UroToday Inc.) - Extirpative surgery in the elderly or high-risk patient can be a daunting undertaking.
read more
|
When to Biopsy a Renal Mass in a Patient with a History of a Nonrenal Malignancy?: Guidelines for Management.
Monday, 11 October 2004
Although symptomatic metastases to the kidney from other malignancies are rare, an increasing number of patients with nonrenal malignancies have renal masses diagnosed during routine studies performed for tumor staging or surveillance.
read more
|
Laparoscopic Nephrectomy in Elderly Patients is as Safe as in Younger Patients
Friday, 08 October 2004
BERKELEY, CA (UroToday Inc.) - Laparoscopic renal surgery is suggested to provide oncologic equivalency to open renal surgery, yet it also facilitates patient recovery and return to full activity.
read more
|
Laparoscopic Partial Nephrectomy: Evaluation of Long-Term Oncological Outcome
Tuesday, 05 October 2004
BERKELEY, CA (UroToday Inc.) - Laparoscopic partial nephrectomy is gaining acceptance as a treatment option for small (< 4cm), organ-confined renal tumors.
read more
|
BJUI Mini Reviews - Conservative vs Radical Surgery for Renal Cell Carcinoma
Friday, 01 October 2004
Login to read more...
|
A Cut-off of Four Centimeters for Stage T1 Renal Cell Carcinoma may Best Predict Patient Outcome
Friday, 24 September 2004
BERKELEY, CA (UroToday Inc.) - A cut-off point of 4 cm may be more practical for discrimination between stage T1 and T2 tumors in organ confined renal cell carcinoma rather than the current cut-off point of 7 cm.
read more
|
Laparoscopic Live Donor Nephrectomy: Trends in Donor and Recipient Morbidity Following 381 Consecutive Cases
Wednesday, 15 September 2004
BERKELEY, CA (UroToday Inc.) - In less than a decade the originators of laparoscopic donor nephrectomy have perfected, promulgated, and taught their technique until it has now come to pervade a majority of transplant programs in the United States.
read more
|
MRI Successfully Guides RF Kidney Tumor Ablation
Tuesday, 14 September 2004
NEW YORK (Reuters Health) - The results of a phase II clinical trial indicate that interactive magnetic resonance imaging (MRI) is effective in guiding radiofrequency (RF) interstitial thermal ablation of primary renal tumors, researchers report in the September issue of Radiology.
read more
|
Enhanced Renal Parenchymal Cryoablation with Novel 17-Gauge Cryoprobes
Thursday, 02 September 2004
BERKELEY, CA (UroToday Inc.) - Less is more! The benefits of technology have turned the "bigger is better" paradigm upside down.
read more
|
Anti-EGF Receptor Antibody has Low Antitumor Action in Renal Cancer
Thursday, 26 August 2004
NEW YORK (Reuters Health) - In patients with metastatic renal cell carcinoma, the anti-epidermal growth factor receptor antibody ABX-EGF shows favorable safety and pharmacokinetics, but little antitumor activity, according to a report in the August 1st issue of the Journal of Clinical Oncology.
read more
|
Nuclear Renal Scan May Accurately Predict Postoperative Renal Function and Adaptive Hyperfunction of the Remaining Kidney after Nephrectomy for Renal Cell Carcinoma
Friday, 20 August 2004
BERKELEY, CA (UroToday Inc.) - It has been clearly shown that the removal of a kidney from a patient with 2 normally functioning kidneys results in functional adaptation and compensatory hypertrophy of the remaining kidney.
read more
|
Partial Nephrectomy with Fibrin Glue Repair: Measurement of Vascular and Pelvicaliceal Hydrodynamic Bond Integrity in a Live and Abbatoir Porcine Model
Tuesday, 17 August 2004
BERKELEY, CA (UroToday Inc.) - The most technically challenging aspect of partial nephrectomy
is the control of parenchymal bleeding and effective closure of the pelvicaliceal system.
read more
|
Increased Diesel Exhaust Exposure Increases Risk of Ovarian Cancer
Monday, 16 August 2004
NEW YORK (Reuters Health) - The risk of ovarian cancer, but not esophageal or testicular cancers, increases with increased exposure to diesel exhaust, according to a new study in the August 20th issue of the International Journal of Cancer.
read more
|
Fusion Cell Vaccine Helpful in Breast and Kidney Cancer
Thursday, 29 July 2004
NEW YORK (Reuters Health) - In a phase I study, two women with metastatic breast cancer experienced significant tumor regression after being treated with a vaccine prepared by fusing whole autologous tumor cells and dendritic cells (DCs).
read more
|
Physical Symptoms Predict Survival Time in Terminal Cancer
Tuesday, 27 July 2004
NEW YORK (Reuters Health) - Physical symptoms that affect health-related quality-of-life (QOL), such as nausea and dyspnea, appear to be associated with shorter survival in terminal cancer patients, researchers report in the July 26th online edition of Cancer.
read more
|
Nephron Sparing Surgery Feasible For Hereditary Renal Tumors
Friday, 16 July 2004
NEW YORK (Reuters Health) - In patients with hereditary renal cancers who are at risk for bilateral metachronous tumors, nephron sparing surgery helps to preserve renal function and prevent the morbidity and mortality associated with dialysis or kidney transplantation.
read more
|
Radiofrequency Ablation of Small Renal Tumors: Intermediate Results
Thursday, 15 July 2004
BERKELEY, CA (UroToday Inc.) - The efficacy of percutaneous radiofrequency ablation of renal tumors has been called into question due to the excellent independent studies coming from the University of Toronto and the Lahey Clinic in 2002.
read more
|
Radiofrequency Ablation Effective Against Renal Cell Carcinomas
Friday, 09 July 2004
NEW YORK (Reuters Health) - CT-guided radiofrequency (RF) ablation can be effective against localized renal cell carcinomas in patients who are unable to undergo surgery, according to a report in the July American Journal of Roentgenology.
read more
|
Doxycycline Effective in Treatment of Chronic Urethral and Pelvic Pain and Refractory Urinary Urgency and Frequency
Friday, 02 July 2004
BERKELEY, CA (UroToday Inc.) - Persistent urinary urgency and frequency and chronic urethral and/or pelvic pain in women are often a diagnostic and therapeutic challenge that can be frustrating for patients and physicians.
read more
|
Laparoscopic Nephrectomy is Safe for Older Kidney Donors
Tuesday, 22 June 2004
NEW YORK (Reuters Health) - In older individuals who opt to donate a kidney, nephrectomy can be performed laparoscopically, with no increase in complication rates for either the donor or the recipient.
read more
|
Quality of Life for Cancer Patients May Be All in the Genes
Thursday, 10 June 2004
NEW ORLEANS (Reuters Health) - The results of a new study provide preliminary evidence of a "potentially strong and specific" relationship between the genetic makeup of cancer patients and their quality of life (QOL) during cancer treatment.
read more
|
Sodium Bicarbonate Infusion Found to Reduce Risk of Contrast-Induced Nephropathy
Tuesday, 08 June 2004
BERKELEY, CA (UroToday Inc.) - Contrast-induced nephropathy remains a common complication of radiographic procedures.
read more
|
Investigational Drug Shrinks Advanced Renal Cell Tumors
Tuesday, 08 June 2004
NEW ORLEANS (Reuters Health) - Interim results from a phase II trial of the investigational drug BAY 43-9006 (sorafenib) indicate that it can produce significant and durable responses in patients with advanced renal cell cancer (RCC).
read more
|
Bevacizumab Plus Erlotinib Highly Active in Advanced Kidney Cancer
Tuesday, 08 June 2004
NEW ORLEANS (Reuters Health) - The combination of two targeted drugs -- bevacizumab (Avastin) and erlotinib (Tarceva) -- appears to be "one of the most active and best tolerated regimens yet tested" in patients with metastatic renal cell carcinoma (RCC), according to a researcher who presented phase II results at the 40th annual meeting of the American Society of Clinical Oncology.
read more
|
Departmental Audit of Large Radiology Department Shows Importance of Close Working Relationship with Urologists when Dealing with Percutaneous Nephrostomy
Friday, 04 June 2004
BERKELEY, CA (UroToday Inc.) - Percutaneous nephrostomy (PCN) is one of the most commonly performed interventional procedures.
It is performed by many general and almost all interventional radiologist
read more
|
Cancer Deaths Down in U.S.: Report
Friday, 04 June 2004
WASHINGTON (Reuters) - More Americans are surviving cancer for 5years or longer and cancer rates overall are steadily declining, according to the latest annual report on cancer in the United States issued on Thursday.
read more
|
Complications of Contemporary Radical Nephrectomy: Comparison of Open vs. Laparoscopic Approach
Thursday, 27 May 2004
BERKELEY, CA (UroToday Inc.) - Laparoscopic surgery offers several advantages over traditional open surgery particularly with regard to less post-operative pain, earlier recovery, decreased length of hospital stay and decreased total time of convalescence.
read more
|
CT-Guided Percutaneous Gene Therapy Injections Safe for Renal Cell Metastases
Friday, 07 May 2004
NEW YORK (Reuters Health) - In patients with metastatic renal cell carcinoma, gene therapy can be safely delivered via computed tomography (CT)-guided percutaneous intratumoral injections, according to a new study.
read more
|
Laparoscopic Radical Nephrectomy Proven to be a Routine and Effective Treatment for Many with Renal Cell Carcinoma
Thursday, 22 April 2004
Renal cell carcinoma is likely to become one of the most important indications for laparoscopic surgery. The laparoscopic technique combines the benefits of the minimally invasive approach with established oncologic surgical principles.
read more
|
Cancer Trial Participants Rarely Told of Results
Wednesday, 21 April 2004
NEW YORK (Reuters Health) - Cancer patients who participate in clinical trials are often left in the dark about the results of the studies, according to a new report.
read more
|
Renal Function Tied to Liver Cancer Mortality
Friday, 16 April 2004
NEW YORK (Reuters Health) - In patients undergoing percutaneous injection therapy for hepatocellular carcinoma (HCC), renal problems may indicate a poor prognosis, according to Taiwanese researchers.
read more
|
Onyx, Bayer Cancer Drug Gets FDA Fast Track Tag
Tuesday, 06 April 2004
NEW YORK (Reuters) - Onyx Pharmaceuticals Inc. and a unit of German drugmaker Bayer AG on Monday said their experimental treatment for advanced kidney cancer has received fast track status from U.S. regulators.
read more
|
Tumor-size Breakpoint for Prognostic Stratification of Localized Renal Cell Carcinoma
Monday, 29 March 2004
BERKELEY, CA (UroToday Inc.) - Pathologic stage remains the most important prognostic predictor in patients with renal cell carcinoma (RCC).
read more
|
Techniques of Needle-Based Ablation of Renal Tumors Examined and Reviewed
Thursday, 25 March 2004
Small renal tumors are commonly detected incidentally during the screening of patents for abdominal symptoms.
read more
|
New tumor classification scheme unlinks tumor type from tumor site
Wednesday, 24 March 2004
NEW YORK (Reuters Health) - A radically different new system for classification of tumors has been set forth by a National Cancer Institute official.
read more
|
New Tumor Classification Scheme Unlinks Tumor Type From Tumor Site
Wednesday, 24 March 2004
NEW YORK (Reuters Health) - A radically different new system for classification of tumors has been set forth by a National Cancer Institute official.
read more
|
Aprepitant Regimen Sustains Antiemetic Effect Over Multiple Chemotherapy Cycles
Tuesday, 23 March 2004
NEW YORK (Reuters Health) - The addition of the drug aprepitant to other antiemetic therapy is associated with less nausea and vomiting during an initial cycle of chemotherapy, and the response is maintained well during subsequent cycles, investigators report.
read more
|
Surgical Kidney Revascularization Proven Effective with High Long-Term Efficacy in Treatment of Hypertension and Preservation of Renal Function
Tuesday, 16 March 2004
Ischemic nephropathy, defined as a physiologically important decrease in glomerular filtration rate with a hemodynamically significant decrease in renal blood flow, accounts for 5-15% of the general hypertensive population requiring renal replacement therapy.
read more
|
Multiple factors Contribute to Renal Cancer Survival
Wednesday, 10 March 2004
NEW YORK (Reuters Health) - A three-factor list developed for use in clinical trial design is helpful in categorizing relative survival in previously treated patients with metastatic renal cell carcinoma, according to New York-based researchers.
read more
|
Bush Replaces Advisers on Cloning, Medical Issues
Tuesday, 02 March 2004
WASHINGTON (Reuters) - President Bush reshuffled his advisory council on cloning and related medical issues on Friday, adding a prominent neurosurgeon known for his work on conjoined twins and two conservatives who have spoken out strongly against cloning.
read more
|
Alternative Therapies Popular with Cancer Patients
Tuesday, 24 February 2004
NEW YORK (Reuters Health) - Insured cancer patients in the State of Washington are considerably more likely to use complementary and alternative medical providers than are insured patients without the disease, researchers report in the February 23rd online edition of Cancer.
read more
|
Vaccine Strategy Reduces Risk of Renal Cell Cancer Progression
Friday, 20 February 2004
NEW YORK (Reuters Health) - Adjuvant treatment with an autologous renal tumor cell vaccine reduces the risk of tumor progression after radical nephrectomy for renal cell carcinoma, according to a report published in the February 21st issue of The Lancet.
read more
|
Natural History of Small Renal Masses Reveals Slow Growth and Low Metastatic Potential
Friday, 13 February 2004
An increasing number of incidental renal masses are detected with more widespread use of ultrasonography, computerized tomography (CT) and magnetic resonance imaging.
read more
|
Renal Cancer 
